Influence of container structures and content solutions on dispensing time of ophthalmic solutions [0.03%]
容器结构和内容物配方对眼部溶液给药时间的影响
Keiji Yoshikawa,Hiroshi Yamada
Keiji Yoshikawa
Purpose: To investigate the influence of container structures and content solutions on the time of dispensing from eye dropper bottles. Methods: ...
Corneal cell viability and structure after transcorneal freezing-thawing in the human cornea [0.03%]
人眼角膜经角膜冷冻后再 thawing后的角膜细胞活力和结构状况
Joo Youn Oh,Hyun Ju Lee,Sang In Khwarg et al.
Joo Youn Oh et al.
Purpose: Although cryotherapy has long been used to eradicate corneal lesions, there have been no reports of adverse effects of cryotherapy on human corneas. We performed this study to evaluate and characterize ultrastruc...
Mirtogenol potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects [0.03%]
米尔朵根改善原态受试者眼压及眼部血流动力学的作用机制：一项随机、双盲、安慰剂平行对照研究
Robert D Steigerwalt Jr,Gianni Belcaro,Paolo Morazzoni et al.
Robert D Steigerwalt Jr et al.
Purpose: The dietary supplement Mirtogenol((R)) was previously shown to lower elevated intraocular pressure (IOP). We here present the effects of this supplement on IOP in comparison as well as in combination with latanop...
Diffractive multifocal intraocular lens interferes with intraoperative view [0.03%]
多焦点人工晶状体的衍射效应干扰手术视野
Mami Yoshino,Makoto Inoue,Nae Kitamura et al.
Mami Yoshino et al.
We report an unusual finding during vitreous surgery in an eye implanted with a diffractive multifocal intraocular lens (IOL). A 70-year-old woman reported gradual visual deterioration to 20/40 in the left eye two and a half years after une...
Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy [0.03%]
从单药或联合治疗转换为曲伏前列素/托溴铵固定复方制剂(DuoTrav)的眼用液的安全性和疗效的多中心研究
Norbert Pfeiffer,Maria-Luise Scherzer,Hubert Maier et al.
Norbert Pfeiffer et al.
Purpose: To assess the safety and efficacy of changing to the travoprost/timolol fixed combination (TTFC) from other mono- or adjunctive therapies. Patien...
Predictability and stability of refraction with increasing optical zone diameter in hyperopic LASIK [0.03%]
激光角膜屈光术治疗远视眼时光学区直径加大与屈光稳定性和可预测性的关系研究
Mostafa A El-Helw,Ahmed M Emarah
Mostafa A El-Helw
Objective: We undertook a prospective nonrandomized study to assess refractive outcome and patient satisfaction with hyperopic laser in situ keratomileusis (LASIK) using variable optical zone diameters in correction of hy...
Comparison of clear lens extraction and collamer lens implantation in high myopia [0.03%]
高度近视眼内晶状体摘除与Collamer人工晶状体植入的对比研究
Ahmed M Emarah,Mostafa A El-Helw,Hazem M Yassin
Ahmed M Emarah
Aim: To compare the outcomes of clear lens extraction and collamer lens implantation in high myopia. Patients and methods: Myopic patie...
First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results [0.03%]
前列腺素类药物新使用者一线治疗费用：荟萃分析结果
Jordana K Schmier,David W Covert
Jordana K Schmier
Objective: To estimate first-year treatment costs among new initiators of topical prostaglandin analogs in a managed care population. Research design and ...
Hyperbaric oxygen therapy for the treatment of radiation-induced macular ischemia [0.03%]
高压氧治疗放射性黄斑缺血的有效性及安全性
Shamim A Haji,Ronald Ep Frenkel
Shamim A Haji
Purpose: To report a case of radiation-induced macular ischemia where vision and macular perfusion improved after hyperbaric oxygen (HBO) therapy. Methods...
Collin M McClelland,George J Harocopos,Philip L Custer
Collin M McClelland
Imatinib mesylate (Gleevec((R))) is a well-established pharmacologic treatment for all phases of chronic myeloid leukemia and for advanced gastrointestinal stromal tumors (GISTs). Edema-related side effects are relatively common in imatinib...